Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,842.00
Bid: 2,839.00
Ask: 2,840.00
Change: -3.00 (-0.11%)
Spread: 1.00 (0.035%)
Open: 2,843.00
High: 2,853.00
Low: 2,816.00
Prev. Close: 2,845.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q1 performance update

31 Jul 2019 07:00

RNS Number : 2735H
3i Group PLC
31 July 2019
 

31 July 2019

 

 

3i Group plc

FY2020 Q1 performance update

 

A good start to the year

 

·; Increase in NAV per share to 864 pence (31 March 2019: 815 pence) and total return of 6.2% for the three months to 30 June 2019

 

·; Completed £139 million Private Equity investment in Magnitude Software Inc and signed the US Infrastructure investment in Regional Rail, LLC, which completed in early July

 

·; Strong share price performance from 3i Infrastructure plc ("3iN"), which completed its investment in Joulz and announced a bolt-on investment for Valorem

 

Simon Borrows, Chief Executive, commented:

 

"This was another good quarter for 3i. Our Private Equity portfolio performed well with Action again generating good growth, as well as 3iN delivering another strong share price performance. Both our Private Equity and Infrastructure teams had a busy quarter on origination and investment. Our balance sheet is well-funded but we remain cautious about the pricing of private investments in the current environment and have continued to focus on platform and bolt-on acquisitions."

 

 

Private Equity

 

Portfolio performance

 

The Private Equity portfolio generated good returns for the quarter. Action has performed strongly since the end of 2018, trading ahead of its budget for the first six months of 2019, with good cash generation and a further improvement in year to date like-for-like sales growth, which is now at 5%. The two new distribution centres which opened in early 2019 are operating well, with much improved stock availability as a result. Action opened 86 new stores in the six months to 30 June 2019, resulting in a total store count of 1,409.

 

We continue to see challenging macro-economic headwinds in Europe and in China specifically in the automotive sector, which is affecting some of our European headquartered industrial companies. However, there is little overall change to the momentum of our Private Equity portfolio.

 

 

Private Equity investments

 

In May 2019, we completed our £139 million investment in Magnitude Software Inc, a leading providerof unified application data management solutions. We have continued to grow portfolio value through our buy-and-build strategy, with Havea Group (formerly Ponroy Santé) completing its acquisition of Pasquali Healthcare and Christ acquiring Valmano, an online retailer of jewellery and watches in Germany. These acquisitions were funded directly by the portfolio companies and did not require any further investment from 3i. In July, Formel D agreed to acquire CPS, a provider of quality assurance services to the automotive industry headquartered in France, and Lampenwelt agreed to acquire QLF Group, one of the leading online lighting players in the Benelux. There is a good pipeline of further acquisition opportunities for a number of companies in the portfolio.

 

During the period, we took the opportunity to purchase three additional LP stakes in EFV, with 3i's investment totalling £61 million. These purchases increased 3i's holding in Action to 45.3% (31 March 2019: 44.3%).

Since the quarter end, we have announced our investment in Evernex, a leading international provider of third-party maintenance services for data centre infrastructure. The investment is expected to complete by the end of 2019.

 

 

Infrastructure

 

The Infrastructure business had another busy quarter. 3iN completed its investment in Joulz in April 2019 and in July agreed to invest c.€220 million in Ionisos, a leading owner and operator of cold sterilisation facilities headquartered in France. In addition, 3iN's portfolio company Valorem agreed to acquire a 51% stake in Force Hydraulique Antillaise SAS. 3iN's share price performed strongly, generating unrealised value growth of £58 million for 3i, in addition to dividend income of £12 million.

In April 2019 we announced that the 3i European Operational Projects Fund had agreed to invest over €100 million in four projects across Europe, taking total investment to c.40% of the fund. We also announced the US Infrastructure team's agreement to invest in Regional Rail, LLC and this investment completed in early July. The infrastructure market remains very active and our Infrastructure team is working on a pipeline of interesting investment opportunities in Europe and North America.

 

 

Top 10 investments by value at 30 June 2019

 

Valuation

Valuation

Valuation

Valuation

Mar-19

Jun-19

basis

currency

£m

£m

Activity in the quarter

Action

Earnings

EUR

2,731

3,076

3iN

Quoted

GBP

744

799

Accrued a £12 million FY2019 final dividend

Scandlines

DCF

EUR

529

555

Received a £6 million dividend

Hans Anders

Earnings

EUR

246

306

Basic-Fit

Quoted

EUR

254

271

Audley Travel

Earnings

GBP

270

270

WP

Earnings

EUR

241

253

Cirtec Medical

Earnings

USD

248

253

Q Holding

Earnings

USD

241

247

Havea

Earnings

EUR

174

190

The 10 investments in this table comprise 75% (31 March 2019: 75%) of the total Proprietary Capital portfolio value of £8,295 million (31 March 2019: £7,553 million).

 

 

Total return and NAV position

 

We recognised a net £212 million gain on foreign exchange in the quarter, as both the US dollar and euro strengthened against sterling. Based on the balance sheet at 30 June 2019, a 1% movement in the euro and US dollar would result in a total return movement of £48 million and £12 million respectively, net of any hedging. The diluted NAV per share increased to 864 pence (31 March 2019: 815 pence) or 844 pence after deducting the 20 pence per share second FY2019 dividend, which was paid on 19 July 2019.

 

 

Balance sheet

 

At 30 June 2019 net cash was £307 million. The 20 pence second FY2019 dividend of £194 million was paid on 19 July 2019.

 

 

- ENDS -

 

 

Notes

 

1.

Balance sheet values are stated net of foreign exchange translation. Where applicable, the GBP equivalents at 30 June 2019 in this update have been calculated at a currency exchange rate of 1.1173:£1 and $1.2718:£1 respectively. At 30 June 2019, 63% of the Group's net assets were in euro and 16% were in US dollar.

2.

At 30 June 2019 3i had 973 million diluted shares.

3.

Action was valued using a post discount run-rate EBITDA multiple of 18.0x based on its run-rate earnings to 30 June 2019.

 

 

For further information, please contact:

Silvia SantoroInvestor Relations DirectorTel: 020 7975 3258

Kathryn van der Kroft

Communications DirectorTel: 020 7975 3021

 

About 3i Group

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

 

All statements in this performance update relate to the three month period ended 30 June 2019 unless otherwise stated. The financial information is unaudited and is presented on 3i's non-GAAP Investment basis in order to provide users with the most appropriate description of the drivers of 3i's performance. Net asset value ("NAV") and total return are the same on the Investment basis and on an IFRS basis. Details of the differences between 3i's consolidated financial statements prepared on an IFRS basis and under the Investment basis are provided in the 2019 Annual report and accounts. There have been no material changes to the financial position of 3i from the end of this quarter to the date of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSDSFWSFUSEFW
Date   Source Headline
1st May 20248:58 amRNSDirector/PDMR Shareholding
30th Apr 20244:34 pmRNSTotal Voting Rights
2nd Apr 20248:01 amRNSPortfolio Update
28th Mar 20241:02 pmRNSTotal Voting Rights
28th Mar 20241:00 pmRNSDirector/PDMR Shareholding
21st Mar 20241:53 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSAction Capital Markets Seminar & portfolio update
1st Mar 202410:11 amRNSDirector/PDMR Shareholding
29th Feb 20244:21 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNS3i Group plc - Q3 performance update
31st Jan 20244:17 pmRNSTotal Voting Rights
31st Jan 20244:14 pmRNSDirector/PDMR Shareholding
4th Jan 20243:36 pmRNSTotal Voting Rights
4th Jan 20243:35 pmRNSDirector/PDMR Shareholding
3rd Jan 202412:00 pmRNSPortfolio Update
8th Dec 20231:11 pmRNSBlock listing Interim Review
30th Nov 20234:55 pmRNSTotal Voting Rights
30th Nov 20234:51 pmRNSDirector/PDMR Shareholding
23rd Nov 202311:11 amRNSDirector Declaration
20th Nov 20239:13 amRNSDirector Declaration
9th Nov 20232:29 pmRNSDirector/PDMR Shareholding
9th Nov 202311:49 amRNSDoc re. Half Yearly Report 2023
9th Nov 20237:00 amRNSHalf-year Report
31st Oct 20233:29 pmRNSTotal Voting Rights
31st Oct 20233:27 pmRNSDirector/PDMR Shareholding
2nd Oct 202312:58 pmRNSDirector/PDMR Shareholding
2nd Oct 202310:36 amRNSPortfolio Update
28th Sep 20231:35 pmRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSUpdate on portfolio and Capital Markets Seminar
12th Sep 202310:43 amRNSDirector/PDMR Shareholding
4th Sep 202310:41 amRNSDirector/PDMR Shareholding
31st Aug 20233:56 pmRNSTotal Voting Rights
31st Aug 20233:52 pmRNSDirector/PDMR Shareholding
1st Aug 202311:40 amRNSDirector/PDMR Shareholding
31st Jul 20234:31 pmRNSTotal Voting Rights
31st Jul 20234:27 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFY2024 Q1 performance update
3rd Jul 202310:25 amRNSPortfolio Update
30th Jun 20233:43 pmRNSTotal Voting Rights
30th Jun 20233:37 pmRNSDirector/PDMR Shareholding
30th Jun 202311:01 amRNSDirector/PDMR Shareholding
29th Jun 20235:00 pmRNSDirectorate Change
29th Jun 20233:46 pmRNSDirector/PDMR Shareholding
29th Jun 20233:31 pmRNSDoc re. AGM Resolutions
29th Jun 20233:30 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM and portfolio update
28th Jun 20232:34 pmRNSDirector/PDMR Shareholding
12th Jun 20232:33 pmRNSPublication of a Prospectus
9th Jun 20239:44 amRNSBlock listing Interim Review
8th Jun 20232:51 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.